Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Block in Shoulder Surgery
NCT03643913Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2018
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium (2 arms), sponsored by UZ Leuven. Primary endpoints: Modified Leiden score at Day 1 and Visual Analogue Scale at Day 3. Started Dec 2018; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT03643913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03643913.